MarketInOut Stock Screener Log In | Sign Up

Biotechnology Assets S.A.

BME • Healthcare • Biotechnology • Quote as of 10/27/2026 17:35
Biotechnology Assets S.A. stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBME
Market Capitalization15.07 mln
Float18.20 mln
Earnings Date10/30/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.53
Likely reliable

Relative Strength

41 / 100
Slightly lagging

Debt / Equity

0.28
Very low leverage

Pre-Tax Margin

-52%
Severely loss-making

ROE

-32.55
Deeply negative

Business Description

Biotechnology Assets S.A. is a Spanish biotech company headquartered in Cádiz that sells specialized tools and technologies to pharmaceutical, agricultural, cosmetic, veterinary, and chemical businesses across Spain and global markets. Its product lineup includes several protein engineering solutions, such as systems for building vaccines without adjuvants, tools for creating cleaner proteins in a single step, and a flexible platform for cancer cell therapy. The company serves both domestic and international clients seeking advanced biological research and development capabilities.

Key Fundamentals

EPS-0.03
ROE-32.55
RPS0.05
ROIC-13.86
ROA-13.75
Interest Cover-11.17
EBITDA, mln0.59
EV / EBITDA26.55
EV / EBIT-10.98
Revenue, mln3.09
EV / Revenue5.07

Quote Details

Last 0.196
Change -0.008 (-3.92%)
Open 0.1935
Volume 33,272
Turnover 6,521.31
Average Volume 159,508

Financial Ratios

Pre-Tax Profit Margin-52
Leverage Ratio2.20
Current Ratio1.40
Price / Book2.26
Price / Tangible Book6.40
Price / Free Cash Flow192
Debt / Equity0.28
Price / Sales4.47

Financial Strength

Altman Z-Score-1.45
Piotroski F-Score 6 / 9
Beneish M-Score-2.53

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.92% 15 / 100   
1 Month -2% 53 / 100   
2 Months -5.77% 40 / 100   
6 Months -24.62% 10 / 100   
1 Year -43.84% 7 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog